Our ambition is to change lives by changing the course of blood cancer.

Powered by pioneering science

Investor Event

Earnings.

Geron reports third quarter 2024 financial results and business highlights ›

Research & Development

Two people engaged in discussion at a conference table.

Developing innovative medicines for myeloid hematologic malignancies >

Patients

woman in glasses smiling

We are on a mission to extend and enhance patients’ lives ›

Culture

A man with gray hair wearing a dark blue blazer and light blue shirt looks off to the side with a thoughtful expression.

We see things in ways others do not ›

Careers

Join us and become a part of something special